Sort
78,016 grants matching “breast cancer”
Novel Biomarkers for Aromatase Inhibitor Therapy
$637,708Washington University · R01 · FY2004 · CA
POPULATION-BASED GENETIC RISK INTERVENTION VIA THE WEB
$637,704Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA
LRH-1, A NEW MOLECULAR TARGET FOR BREAST CANCER TREATMENT
$637,703Hudson Institute Of Medical Research · · FY2010 · Department of Defense
Multifactoral breast cancer risk prediction accounting for ethnic and tumor diversity
$637,691Peter Kraft · Harvard School Of Public Health · U01 · FY2021 · CA
Dynamic Imaging of EMT in the Breast Cancer Microenvironment
$637,623Christopher H Contag · Stanford University · R01 · FY2015 · CA
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
$637,586Lenora Wm Loo · University Of Hawaii At Manoa · R01 · FY2019 · CA
Quantitative Ultrasound Analysis of Vascular Morphology for Cancer Assessment
$637,563Stephen R Aylward · Kitware, Inc. · R44 · FY2015 · CA
Sex Hormone Receptor Components and the Cell Genome
$637,549Bert W O'Malley · Baylor College Of Medicine · R01 · FY2021 · HD
Evaluation of novel tomosynthesis density measures in breast cancer risk prediction
$637,516Celine M Vachon · Mayo Clinic Rochester · R01 · FY2024 · CA
Metabolic activation of nitroarenes and Nrf2-Keap1
$637,502Trevor M. Penning · University Of Pennsylvania · R01 · FY2025 · ES
STRUCTURE-BASED INHIBITORS OF BRCA1 TO ENHANCE THE BREAST CANCER SENSITIVITY TO RADIATION THERAPY AND CHEMOTHERAPYY
$637,500Beth Israel Deaconess Medical Center, Inc. · · FY2010 · Department of the Army
NEW MECHANISMS FOR BREAST CANCER TRANSMIGRATION ACROSS THE BLOOD BRAIN BARRIER
$637,500Beth Israel Deaconess Medical Center, Inc. · · FY2010 · Department of the Army
Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia
$637,457Amy C Degnim · Mayo Clinic Rochester · R01 · FY2024 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center
$637,440Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2024 · CA
Predicting Breast Cancer Risk after Benign Percutaneous Biopsy
$637,416Mark E Sherman · Mayo Clinic Jacksonville · R01 · FY2021 · CA
Regulatory immune cells in immune suppression: The role of tBregs
$637,389Arya Biragyn · National Institute On Aging · ZIA · FY2019 · AG
Development of an ultrasound detectable, migration-resistant biopsy marker for improving care in patients with breast cancer
$637,358Matthew William Urban · Mayo Clinic Rochester · R01 · FY2023 · EB
High Content Representation and Association of 3D Cell Culture Models
$637,355Bahram A. Parvin · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2011 · CA
Racial/Ethnic and SES Disparities in Quality of Breast Cancer Systemic Therapy
$637,278Jennifer J Griggs · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
High Performance, Quantitative Breast PET Scanner Integrated with Tomosynthesis
$637,215Suleman Surti · University Of Pennsylvania · R01 · FY2018 · CA
"Patient Navigation in the SafetyNet: CONNECTeDD"
$637,203Boston Medical Center · U01 · FY2005 · CA
Fine-mapping of 8q24 and Loci Identified in Genome-Wide Studies for Breast & Colo
$637,181Christopher Alan Haiman · University Of Southern California · R01 · FY2010 · CA
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
$637,172Theresa A Guise · Indiana University Indianapolis · R01 · FY2017 · CA
Relationships between parity, breastfeeding and ER- breast cancer in African American women: Elucidating the biologic underpinnings at the molecular and cellular level.
$637,155Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Methods for Epidemiology Studies
$637,142Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA